Waterfront Wealth Inc. Buys 3,769 Shares of Teleflex Incorporated $TFX

Waterfront Wealth Inc. boosted its position in Teleflex Incorporated (NYSE:TFX) by 22.4% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 20,568 shares of the medical technology company’s stock after purchasing an additional 3,769 shares during the period. Waterfront Wealth Inc.’s holdings in Teleflex were worth $2,460,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of TFX. Banque Cantonale Vaudoise raised its stake in shares of Teleflex by 82.5% in the fourth quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company’s stock valued at $31,000 after buying an additional 113 shares during the period. V Square Quantitative Management LLC purchased a new stake in Teleflex in the 4th quarter worth about $37,000. UMB Bank n.a. increased its holdings in Teleflex by 57.1% in the 4th quarter. UMB Bank n.a. now owns 311 shares of the medical technology company’s stock worth $38,000 after acquiring an additional 113 shares during the last quarter. Sound Income Strategies LLC bought a new stake in Teleflex in the 4th quarter valued at about $45,000. Finally, Kestra Advisory Services LLC bought a new stake in Teleflex in the 4th quarter valued at about $45,000. 95.62% of the stock is owned by institutional investors.

Teleflex Trading Up 2.9%

Shares of Teleflex stock opened at $134.16 on Friday. Teleflex Incorporated has a 12-month low of $100.18 and a 12-month high of $139.67. The company has a market cap of $5.94 billion, a price-to-earnings ratio of -5.88, a PEG ratio of 0.97 and a beta of 0.82. The company has a current ratio of 2.55, a quick ratio of 2.03 and a debt-to-equity ratio of 0.82. The company’s 50-day moving average price is $129.72 and its 200-day moving average price is $119.99.

Teleflex (NYSE:TFX) last released its quarterly earnings data on Thursday, May 7th. The medical technology company reported $1.39 EPS for the quarter, beating analysts’ consensus estimates of $1.21 by $0.18. The company had revenue of $548.30 million during the quarter, compared to analyst estimates of $536.91 million. Teleflex had a negative net margin of 35.88% and a positive return on equity of 13.29%. Teleflex’s revenue was up 32.3% compared to the same quarter last year. During the same period last year, the business earned $1.44 earnings per share. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. On average, equities analysts expect that Teleflex Incorporated will post 6.7 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, June 30th. Stockholders of record on Monday, May 25th were given a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date was Friday, May 22nd. Teleflex’s payout ratio is -5.96%.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on TFX. Truist Financial reiterated a “hold” rating and set a $143.00 target price (up from $135.00) on shares of Teleflex in a research report on Monday, May 11th. BMO Capital Markets initiated coverage on shares of Teleflex in a research report on Wednesday. They issued an “outperform” rating and a $159.00 price target on the stock. Royal Bank Of Canada raised shares of Teleflex from a “sector perform” rating to an “outperform” rating and boosted their price target for the company from $135.00 to $155.00 in a research report on Friday, May 8th. Mizuho set a $140.00 price target on shares of Teleflex in a research note on Friday, May 8th. Finally, Piper Sandler raised shares of Teleflex from a “neutral” rating to an “overweight” rating and raised their price objective for the stock from $140.00 to $160.00 in a report on Monday, June 8th. Five analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $147.44.

Teleflex Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.